Delivery Order SPE2DB22D9316-SPE2DB25FYQ04
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $61,902.91 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of MACI 3cm x 5cm implant sheets. The award, issued on July 25, 2025, with an ultimate completion date of August 15, 2025, operates under a firm fixed-price contract type with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $61,902.91 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of MACI 3cm x 5cm implant sheets. The contract is a firm fixed-price delivery order with an ultimate completion date of September 8, 2025, and carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA's SPE2DB...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $61,538.77 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of MACI 3cm x 5cm implant sheets. This firm fixed-price delivery order was awarded on September 10, 2025, with an ultimate completion date of October 1, 2025, and carries no set-aside designation. The contract represents a discrete order issued under DMS Pharmaceutical Group's larger...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $53,318.24 contract is for the delivery of MACI 3CM X 5CM implant sheets to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999,...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $61,538.77 to DMS Pharmaceutical Group Inc. for MACI 3cm x 5cm implant sheets. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its facility in Park Ridge. The contract carries no set-aside designation and has an ultimate completion date of September 24, 2025. This delivery order is issued under DMS...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth up to $57,317.20 to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract, which has a period of performance through April 16, 2024, is for the supply of MACI 3CM X 5CM Implant Sheets. This order was placed under DMS Pharmaceutical Group's existing Indefinite Delivery Vehicle (IDV) contract SPE2DB24FSW93 with DLA, which has a ceiling value of up...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $61,902.91 for MACI 3cm x 5cm implant sheets. The award was issued on July 23, 2025, with an ultimate completion date of August 13, 2025, under a firm fixed-price contract with no set-aside designation. The contract is being funded by the Defense Logistics Agency's Medical Supply Chain and will be performed at the contractor's Park...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the delivery of 4564165994 MACI 3CM X 5CM implant sheets with a potential value of $57,317.20. The contract has a completion date of March 12, 2024 and was awarded on February 20, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that provides a wide range of branded and...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $61,538.77 by the Defense Logistics Agency (DLA) on August 8, 2025. The delivery order, with an ultimate completion date of August 29, 2025, is for MACI 3cm x 5cm implant sheets—a regenerative medicine product used in cartilage repair and orthopedic applications. This award was issued without a set-aside designation, allowing...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $61,902.90 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4567084856 MACI 3CM X 5CM IMPLANT SHEETS, a specialized medical product, with a completion date of February 3, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the...
- SPE2DB22D9316Indefinite Delivery Contract
- SPE2DB22D9316-SPE2DB25FYQ04Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $61,538.77 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of MACI 3cm x 5cm implant sheets. This firm fixed-price delivery order was awarded on September 10, 2025, with an ultimate completion date of October 1, 2025, and carries no set-aside designation. The award was issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion contract vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently delivering specialized medical products to Department of Defense healthcare facilities nationwide. The company's extensive contract portfolio with the DLA demonstrates its capability to supply diverse pharmaceutical items ranging from prescription medications and biologics to medical devices and specialty treatments. This particular delivery order for MACI implants represents another instance of the company's role in supporting military healthcare operations through the provision of advanced pharmaceutical and medical device products.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $61.5k | 9/10/25 |